Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-11
2008-08-26
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S422000, C514S428000, C514S248000, C514S249000, C514S266100, C514S300000, C514S307000, C514S314000, C548S455000, C548S517000, C548S518000, C548S525000, C548S527000, C548S567000, C546S122000, C546S148000, C546S176000, C544S235000, C544S283000, C544S353000
Reexamination Certificate
active
07417062
ABSTRACT:
Substituted benzamide compounds are provided along with methods for the use of those compounds for treating cancer.
REFERENCES:
patent: 2004/0102431 (2004-05-01), Boss et al.
patent: WO 03/055876 (2003-07-01), None
patent: WO 2004/058705 (2004-07-01), None
patent: WO 2005/074645 (2005-08-01), None
patent: WO 2005/087236 (2005-09-01), None
patent: WO 2004/096771 (2005-11-01), None
Ruchelman et al. Bioorganic & Medicinal Chemistry 12 (2004) 795-806.
Melikian Anita
Wright John J. Kim
ChemoCentryx, Inc.
Habte Kahsay T
Townsend and Townsend / and Crew LLP
LandOfFree
Substituted arylamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted arylamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted arylamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4020057